Stockreport

Rocket Pharmaceuticals Announces Clearance of IND for RP-A501 Gene Therapy for Danon Disease

Rocket Pharmaceuticals, Inc.  (RCKT) 
Last rocket pharmaceuticals, inc. earnings: 3/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: rocketpharma.com
PDF - Phase 1 Clinical Trial to Commence in the Second Quarter of 2019 - NEW YORK--(BUSINESS WIRE)-- Rocket Pharmaceuticals, Inc. (Nasdaq: RCKT) ( [Read more]